ArticleSouth Asian journal of cancer

Tolerance and adverse event profile with sorafenib in Indian patients with advanced hepatocellular carcinoma.

Vikas Ostwal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.